NCT01318837View on ClinicalTrials.gov

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Over Active Bladder
Interventions
DRUG

solifenacin

oral

Trial Locations (2)

Unknown

Seoul

Sungnam

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT01318837 - A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment | Biotech Hunter | Biotech Hunter